TAG:
aacc
Staunch Laboratory Advocate Retires After 31 Years of Service
LAST MONTH, THE LABORATORY INDUSTRY lost one its most dedicated, full-time advocates. With his retirement in January, Joe Boone, Ph.D., ended a 31-year career with the Centers for Disease Control and Prevention (CDC). Boone started with the CDC in 1977. In 1992, he …
April 14, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 5 – April 14, 2008 Issue
Psychiatry may soon have its first set of objective clinical laboratory blood tests for mood disorders. Researchers at the Indiana University School of Medicine recently published their findings in Molecular Psychiatry. Working with 11 different genes, they described a “predictive …
Analyzing Lab Bid Demo To Predict Its Outcome
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: After two decades of study and preparation, the Centers for Medicare & Medicaid Services (CMS) is pushing the laboratory profession toward the first pilot site in the Congressionally-mandated Medicare Clinical Laboratory Services Competitive Demonstration Project. Designe…
Using a 1997 Bid Model In a 2007 Health Market
By Robert Michel | From the Volume XIV No. 18 – December 31, 2007 Issue
CEO SUMMARY: It’s been a long path from concept to implementation for a competitive bidding demonstration involving clinical lab services. It was in the mid-1980s when CMS commenced work on designing such a demonstration. In the 1990s, RTI International continued devel…
New Book Offers Guidance About Management of POCT
By Robert Michel | From the Volume XIII No. 14 – October 16, 2006 Issue
WHENEVER A TREND COMES OF AGE, books appear to offer guidance on how to best benefit from such a trend. In the laboratory profession, point-of-care testing (POCT) is an example of a trend which is now ubiquitous in most large healthcare organizations. Another trend currently gathering momentum in bo…
Siemens’ IVD Purchases Are a Major Investment
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
CEO SUMMARY: In the space of just nine weeks, Siemens AG purchased Diagnostic Products Corp. (DPC) and Bayer Diagnostics. Siemens paid $1.86 billion and $5.31 billion, respectively, for the two invitro diagnostics (IVD) companies. Once it closes the acquisition of Bayer Diagnostics, Sieme…
“State of Industry” Report On Molecular Diagnostics
By Robert Michel | From the Volume X No. 10 – July 28, 2003 Issue
CEO SUMMARY: Enterprise Analysis Corporation has launched an ambitious survey that will include 150 laboratories performing molecular testing in the United States. Last week it released information about the first 51 labs contacted in this effort. The survey provides an intriguing look at…
AACC and CAP Meetings Generate Useful Insights
By Robert Michel | From the Volume X No. 10 – July 28, 2003 Issue
IT WAS A BUSY TIME LAST WEEK on the lab industry meeting circuit. THE DARK REPORT made the rounds and uncovered some valuable intelligence for lab directors and pathologists. First on the meeting tour was Philadelphia, site of the American Association of Clinical Chemistry (AACC) a…
“March 24, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 4 – March 24, 2003 Issue
Wholesale prices for general acute care hospitals has climbed steadily in recent months. As tracked by the U.S. Labor Department’s Wholesale Producer Price Index, hospital prices increased 0.5%. For the 12 months ending in February, hospital prices were up 4.7%. This is almost doub…
“November 18, 2002 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
Antitrust regulators are signaling displeasure about a growing number of business activities in healthcare. Timothy Muris, Chairman of the Federal Trade Commission (FTC), was in Chicago on November 7 to address a group of lawyers and business people. He told them that the FTC “cont…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized